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Purpose: The radioiodine ablation therapy is required for patients who underwent a 
total thyroidectomy. Through a comparative review of a low iodine diet (LID) and a 
restricted iodine diet (RID), the study aims to suggest guidelines that are suitable for 
the conditions of Korea. Materials and Methods: The study was conducted with 
101 patients. With 24-hour urine samples from the patients after a 2-week restricted 
diet and after a 4-week restricted diet, the amount of iodine in the urine was esti-
mated. The consumed radioiodine amounts for 2 hours and 24 hours were calculat-
ed. Results: This study was conducted with 47 LID patients and 54 RID patients. 
The amounts of iodine in urine, the 2-week case and 4-week case for each group 
showed no significant differences. The amounts of iodine in urine between the two 
groups were both included in the range of the criteria for radioiodine ablation thera-
py. Also, 2 hours and 24 hours radioiodine consumption measured after 4-week re-
strictive diet did not show statistical differences between two groups. Conclusion: 
A 2-week RID can be considered as a type of radioiodine ablation therapy after pa-
tients undergo a total thyroidectomy.
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INTRODUCTION
Due to increased desire for regular medical check-ups along with the development 
of diagnostic technology, the prevalence rate of thyroid carcinoma has shown an in-
crease domestically. For women, the incidence rate of thyroid cancer had the sec-
ond highest percentage following breast cancer according to the domestic incidence 
rate of cancer in 2005.1 Differentiated thyroid carcinoma, the most commonly oc-
curring type of thyroid carcinoma, is a malignant tumor with a relatively favorable 
prognosis compared to other cancers.2,3 For treatment, radioiodine ablation therapy 
applying iodine-131 (131I) is done for patients who have undergone a total thyroid-
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the patient visited the hospital on the seventh day after their 
operation, they were given an explanation of the research 
objective. If they agreed, the patient was selected as a sub-
ject, in the order of their hospital visit. Patients who did not 
follow the research plan were excluded from analysis. Re-
search objectives were determined considering the opinions 
from diagnostic imaging results, those from surgical find-
ings in operative field, and the histopathology results after 
the surgeries. Once this was determined, the study proceed-
ed. All of the patients were hypothyroid status due to 4 
weeks of T4 withdrawl.
Study design
For this study, the Research Institute of Food & Nutritional 
Sciences at Yonsei University provided meal plans for LID 
and RID and the Department of Nutrition at Shinchon Sev-
erance Hospital educated the patients about the diet.7,9,10
1) The Department of Nutrition and the nutrition coordi-
nators for the research provided the subjects with informa-
tion about the diet and instructed them on how to keep diet 
records. They also provided diet guidelines and sample meal 
plans. Moreover, the patients were trained to keep records on 
two days during the week and on one day over the weekends. 
Diet guidelines and specific lists of approved and restricted 
foods provided to the patients are shown in Table 1 and 2. 
2) Measurement of the amount of urine iodine was done 
after a 4-week restricted diet as well as a 2-week restricted 
diet. For 24 hours, urine was collected without preserva-
tives. After waking up at 6 in the morning on Monday, the 
first urine sample was rejected. The sample came from the 
second production of urine. Urine samples were collected 
until the morning on Tuesday, and patient brought them to 
the hospital. A urine creatinine was determined. Urinary io-
dine was measured by Ion Selective Electrode method. An 
Orion EA 940 ion meter (Orion Research, Boston, MA, 
USA), equipped with an Orion 94-53 iodide-specific ion 
electrode, and an Orion 90-03 double-junction reference 
electrode, was used for determination of iodine. The stan-
dard solution was 0.1 M NaI, and the ionic strength was ad-
justed with 5 M NaNO3. The creatinine in the urine was an-
alyzed by the Jaffe method using Kyobuto company’s 
creatinine kit (Kyobuto, Tokyo, Japan).11 The measured fig-
ure of urine iodine was divided by the amount of urine cre-
atinine to calculate the rate of I/Cr (ug/gCr). 30 mCi was 
administered on Wednesday. Scanning and thyroid function 
examinations were conducted on Friday. Thyroid uptake 
was performed at 2 hours and 24 hours after I-131 adminis-
ectomy. Patients are then monitored by neck ultrasonography 
and measuring the thyroglobulin antigen (Tg-Ag) levels in 
the blood. In positive thyroglobulin antibody (Tg-Ab) pa-
tients, a diagnostic radioiodine whole body scanning (dWBS) 
can also be useful.4 For effective radioiodine ablation thera-
py, a low iodine diet (LID) is implemented for a certain peri-
od.5 Normally, a LID restricts the daily consumption of io-
dine to less than 50 ug; the recommendations released by 
the American Thyroid Association (ATA) in 2006 advise 
carrying out a 1‒2 week restricted diet before radioiodine 
ablation therapy.6 However, as Korea is surrounded on three 
sides by the sea and because Koreans are exposed to rela-
tively more iodine containing food, people consume 468.9 
ug of iodine per day, more than the average amount con-
sumed by Americans, which is 195 ug.7 Against this back-
ground, we considered that new recommendations, different 
from those of the ATA, should be made for Korean patients. 
When implementing a LID for patients, most of them com-
plain about the unpleasantness of maintaining the diet, and 
their quality of life is greatly affected by it. Therefore, some 
hospitals implement a restricted iodine diet (RID) that limits 
the daily consumption of iodine, only partially, to 50‒100 ug.8
Kim, et al.7 reported the effectiveness of a 1-week LID by 
comparing a 1-week LID vs. a 2-week LID, and Tomoda, et 
al.9 reported the effectiveness of a 2-week LID by compar-
ing a 1-week RID vs. a 1-week LID vs. a 2-week LID. 
However, neither study compared RID to LID under the 
same conditions, which made many centers hesitate to apply 
their results in a clinical setting. For this reason, many Kore-
an doctors still prefer 4-week LID despite ATA guide line. 
This is a preliminary study to compare 2-week vs. 4-week 
according to restricted diet methods by analyzing urine sam-
ples and treatment outcomes for patients with differentiated 
thyroid carcinoma who previously underwent a total thy-
roidectomy and undergo radioiodine ablation therapy.
MATERIALS AND METHODS
Patients
Among 108 pattients who had undergone a total thyroidec-
tomy for differentiated thyroid carcinoma and agreed to par-
ticipate in the research at the Thyroid Cancer Clinic of the 
College of Medicine at Yonsei University from March of 
2009 to May of 2010, 101 patients who followed the diet in 
principle were included in this study. Patients with progres-
sive or relapsing thyroid carcinoma were excluded. When 
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RAIU=[neck counts (cpm)-thigh counts (cpm)]/[admin-
istered counts (cpm)-background counts (cpm)].
Statistics
The targeted number of subjects was determined to be 92 
according to a power analysis of a non-inferiority test done 
on the difference of the two means by the Department of 
Biostatistics, however, after confirming no difference be-
tween the two groups by conducting homoscedasticity for 
an intermediate verification when 50% of the targeted num-
ber was filled, recruitment of research subjects was closed. 
A paired t-test and a chi-square test were carried out using 
SPSS v12.0 for Windows (SPSS Inc., Chicago, IL, USA) in 
order to compare and analyze the results and the remedial 
values between the two groups. 
tration. At this time, with the cooperation of the Department 
of Nuclear Medicine, the amount of radioiodine consump-
tion was calculated and the difference between the two 
groups was confirmed. The amount of consumption (%) 
was calculated by comparing consumption at the neck 
based on consumption at the thigh. Thyroid uptake was 
measured using Koroid thyroid uptake system (SeYong 
NDC, Ltd., Seoul, Korea) equipped with single NaI (TI) 
scintillator with PM tube and lead shielded collimator. 
Briefly, the probe was placed approximately 30 cm from 
neck for thyroid uptake counts and thigh for body back-
ground counts. Calibration was done using a known radioio-
dine dose from neck phantom.
Radioiodine uptake (RAIU) was calculated using the fol-
lowing equation:
Table 1. Diet Guidelines for the RID
Group Approved Restricted
Seaweed and seafood
All types of seaweed and seafood (laver, sea  
  mustard, sea tangle, seaweed fusiforme,  
  seastaghorn, sea mustard, shrimp, crab, etc.)
Meat and fish Beef, pork, chicken (max. 200 g) Fish and shellfish ham, sausage, fish paste
Milk and dairy products
Milk and dairy products (choose one: milk, ice-cream,  
  cheese, yogurt), 1 cup of milk less than 200 mL
Eggs General egg (1 per day or less)
Eggs containing iodine (iodine egg, seaweed  
  egg, etc.)
Grains All types
Fruits and vegetables All fruits and vegetables 
RID, restricted iodine diet.
General Instructions: 1. Restrict seaweeds and fish, which are high in iodine; 2. The maximum amount of consumption for beef, pork and chicken is 200 g 
in total per day; 3. Do not use salt containing iodine (Ex: sea salt); 4. Avoid processed, imported, fast foods and eating out as much as possible; 5. Do not 
take vitamin/mineral supplements during the RID period. Specific list of approved and restricted foods.
Table 2. Diet Guidelines for the LID
Group Approved Restricted
Seaweed and seafood
All types of sea vegetable (laver, sea mustard, sea tangle,  
  seaweed fusiforme, seastaghorn, sea mustard) and sea food  
  (crab, oyster, shrimp, etc.)
Fish and shellfish All types of fish and shellfish
Meat Beef, pork, chicken (max. 100 g) Ham, sausage, fish paste
Eggs General egg (1/2 per day or less) Eggs containing iodine (iodine egg, seaweed egg, etc.)
Dairy products Milk and dairy products, soymilk
Grains All types Cereal with red food coloring, bread
Fruits and vegetables All types of raw fruits and vegetables Juice with red food coloring, canned
Others Stock, anchovy stock, udon soup, instant noodles soup, etc. 
LID, low iodine diet. 
General Instructions: 1. Restrict seaweed (laver, sea mustard, sea tangle, seaweed fusiforme, seastaghorn, etc.) and fish; 2. Do not use salt containing 
iodine (Ex: sea salt); 3. Avoid processed and imported foods as much as possible; 4. Do not take vitamin/mineral supplements during the LID period; 5. 
Avoid eating out and fast foods as much as possible; 6. Avoid consuming stock, anchovy stock, udon soup, instant noodle soup, etc.; 7. Avoid food contain-
ing red food coloring (confectionery, candy, juice, cereal, etc.) and drugs (cough syrup, etc.) as much as possible; 8. Avoid salted food (salted fish, pickled 
vegetables, sauce, food containing liquid sauce) as much as possible. Specific list of approved and restricted foods.
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tomy.13 Radioiodine ablation therapy with an application of 
131I has been utilized to treat or examine residual thyroid tis-
sue or metastasized thyroid carcinoma after a total thyroid-
ectomy since Keston, et al.14 reported that radioiodine is 
consumed in tissues in which differentiated thyroid carcino-
ma had metastasized.15 To increase radioiodine uptake, thy-
roid-stimulating hormone (TSH) range can be increased by 
stopping thyroid hormone therapy or by injecting recombi-
nant human TSH (rhTSH). Moreover, by decreasing the con-
centration of iodine through a LID, the sensitivity of residual 
thyroid tissues toward TSH can be increased. In turn, con-
sumption of radioiodine can be increased. Moreover, by in-
creasing sodium iodide symporter (hNIS), specific activity of 
radioiodine can be increased.16,17 Residents in regions lacking 
Ethics statement
This study was approved by the Institutional Review Board 
of the Severance Hospital Institutional Review Board (IRB 
No. 4-2008-0646).
RESULTS
Analysis of the clinical characteristics of patients
The total number of applicants for the research was 108, in-
cluding 52 patients on a LID and 56 patients on a RID, but 5 
from the LID group and 2 from the RID group were exclud-
ed because they did not adhere to the diets. According to the 
analysis of clinical characteristics of the 47 patients on a 
LID and the 54 patients on a RID, there were no statistical 
differences in terms of their age, gender, capsule invasion, 
the maximal size of tumor, multifocality, bilaterality, central 
node invasion, lateral neck node invasion, distant metastasis, 
and serum thyroglobulin level which proved that the sub-
jects for the study were suitably selected (Table 3). 
Analysis of characteristics according to the TNM stage
The patients’ TNM stages were classified based on the 7th 
edition of the American Joint Committee on Cancer (AJCC).12 
The number of patients in Stages I and III were 37 (36.6%) 
and 58 (57.4%), respectively, which accounted for 94.0% 
of the total number of patients. There was no statistical dif-
ference between the LID and RID groups (Table 4). 
Comparison of the urinary I/Cr and urine creatinine 
for the LID and RID groups
According to the paired t-test, no statistical differences exist-
ed in the urine I/Cr and urine creatinine values in each group 
according to diet duration (Table 5). 
Comparison of radioiodine consumption between the 
LID and RID groups
Consumption of radioiodine after 4 weeks of diet restriction 
showed no statistical difference between the two groups at 2 
and 24 hours after consuming radioiodine (Table 6). 
DISCUSSION
Although there have been differing opinions regarding treat-
ments for differentiated thyroid carcinoma, many institutes 
perform radioiodine ablation therapy after a total thyroidec-
Table 3. Clinical Characteristics of the Patients
Total
Diet
Low 
iodine diet
Restricted 
iodine diet
Age (yrs) 52.0 (23‒73) 52.0 (23‒73) 51.5 (24‒72)
Gender
Male 13 6 7
Female 88 41 47
Capsule 
  invasion (%)
No 24 (23.8) 12 (50.0) 12 (50.0)
Yes 77 (76.2) 35 (45.5) 42 (54.5)
Maximal size (cm)     0.9 (0.2‒4.0)    0.9 (0.3‒4.0)    0.8 (0.2‒3.0)
Multifocality (%)
No 60 (59.4) 27 (45.0) 33 (55.0)
Yes 41 (40.6) 20 (48.8) 21 (51.2)
Bilaterality (%)
No 71 (70.3) 30 (4.23) 41 (57.7)
Yes 30 (29.7) 17 (56.7) 13 (43.3)
Central node 
  invasion (%)
No 62 (61.4) 28 (45.2) 34 (54.8)
Yes 39 (38.6) 19 (48.7) 20 (51.3)
Lateral neck node 
  invasion (%)
No 101 (100) 47 (46.5) 54 (53.5)
Yes 0 (0) 0 (0) 0 (0)
Distant 
  metastasis (%)
No 101 (100) 47 (46.5) 54 (53.5)
Yes 0 (0) 0 (0) 0 (0)
Serum Tg* (ng/mL)
1.69 
(0.2‒14.26)
1.28 
(0.21‒92.07)
TSH, thyroid-stimulating hormone.
*Median serum thyroglobulin antigen level with TSH suppression off status.
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almost identical to the average amount consumed by Japa-
nese, at 544 ug.7,22,23 Moreover, Koreans are exposed to rel-
atively more food with high iodine content such as seaweed 
and fish. Accordingly, rather than following the recommen-
dations of the ATA, many institutions actually apply a lon-
ger duration to the restricted diet, considering the character-
istics of Korea. Regarding restricted diets, because Koreans 
and Japanese normally enjoy meals that are high in iodine, 
LID causes considerable discomfort to patients in terms of 
their quality of life. Thus, some studies on RIDs have been 
published in Korea and Japan.8,9 We prepared meal plans for 
RIDs and LIDs that are suitable for conditions in Korea by 
requesting the Research Institute of Foods and Nutritional 
Science at Yonsei University. For the durations of the re-
stricted diets, the analyses were conducted for 2 and 4 weeks, 
which are used mostly in Korean institutions, not based on 
1- and 2-week diets in foreign cases. In general, to measure 
urine iodine (I/Cr), urine is collected in the morning on the 
day of hospitalization for radioiodine ablation therapy, or 
urine collected by the patient over a period of 24 hours is 
used. Research thus far has used the urine produced in the 
morning on the day of the procedure instead of the 24-hour 
concentrated urine in order to measure I/Cr due to the objec-
tions of patients; however, because the output of iodine to 
urine strongly depends on the iodine concentration in the 
blood for the urine in the morning sample, it is difficult to 
measure the amount of I/Cr as precisely as with the 24-hour 
concentrated urine.24,25 In this study, we strictly trained pa-
tients to visit the hospital and deliver 24-hour concentrated 
urine on the 2nd and 4th week of the restricted diets. The 
urine iodine calculation was calculated by dividing it with 
the amount of creatinine. As the measured amount can dif-
fer according to individual body water contents when using 
urine iodine that is not revised by creatinine, it is not easy to 
differentiate if the figure truelly reflects the amount of io-
dine in the body. Thus, it should be revised by urine creati-
nine.18,24 Urine creatinine can differ according to gender and 
age. In general, given that men and the young have more 
muscle tissue than women and the elderly, urine I/Cr tends 
to increase with age, and women tend to have higher figures 
than to men.26,27 In the present study, the ratio of males to 
females was 1:6.8 and the average age was 53 (range: 
23‒72) for the LID group, whereas the ratio of males to fe-
males was 1:6.7 and the average age was 51.5 (24‒72) for 
the RID group; there was no statistical difference between 
the two. Hence, statistical bias can be minimized. One pos-
sible problem when selecting research subjects was that the 
iodine have a daily urine iodine (I/Cr) of <50 ug/gCr on aver-
age, while people living in areas with a normal amount of io-
dine consumption show >100 ug/gCr. Hence, many institu-
tions consider daily urine iodine (I/Cr) <50 ug/gCr amounts 
as the optimal figure for measurement when a patient under-
goes radioiodine ablation therapy. Meanwhile, Park and 
Hennessey18 estimated a range as high as <100 ug/gCr as ap-
propriate.19,20 Many institutions limit the daily amount of io-
dine consumption to <50 ug for a LID and 50‒100 ug for a 
RID prior to radioiodine ablation therapy.21 According to the 
recommendations published by the ATA in 2006, the restrict-
ed diet should be implemented 1‒2 weeks before radioio-
dine ablation therapy.6 In Korea’s case, however, people con-
sume 468.9 ug on average, which is more than the average 
consumption of iodine per day for Americans (195 ug), and 
Table 4. Characteristics According to TNM Stage
Total
Diet
Low iodine 
diet
Restricted  
iodine diet
T stage (%)
T1    21 (20.8)   9 (42.9)    12 (57.1)
T2    3 (3.0)  3 (100) 0 (0)
T3    72 (71.3) 33 (45.8)    39 (54.2)
T4a 5 (5)   2 (40.0)      3 (60.0)
N stage (%)
N0    62 (61.4) 28 (45.2)    34 (54.8)
N1a    39 (38.6) 19 (48.7)    20 (51.3)
M stage
M0 101 (100) 47 (46.5)    54 (53.5)
Over all stage (%)
I    37 (36.6) 15 (40.5)    22 (59.5)
II    1 (1.0)  1 (100) 0 (0)
III    58 (57.4) 29 (50.0)      3 (50.0)
IVa    5 (5.0)   2 (40.0)      3 (60.0)
Table 5. Comparison of Urinary I/Cr and Urine Creatinine Val-
ues for the LID and RID Groups According to Diet Duration
Diet Duration p value
Low iodine diet
Urine I/Cr (ug/gCr)*
2 wks
4 wks
28.6 (23.6)
35.0 (33.0)
0.253
Urine creatinine (mg/dL)*
2 wks
4 wks
110 (85.4)
94.3 (81.3)
0.295
Restricted iodine diet
Urine I/Cr (ug/gCr)*
2 wks
4 wks
35.8 (35.2)
35.0 (31.0)
0.884
Urine creatinine (mg/dL)*
2 wks
4 wks
103.1 (93.2)
112.9 (91.9)
0.530
LID, low iodine diet; RID, restricted iodine diet.
*Mean standard deviation.
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statistical gaps. The amount of radioiodine consumption was 
calculated using gamma-rays from the regions where the 
thyroids were removed, based on the thigh data after a re-
quest to the Department of Nuclear Medicine of Severance 
Hospital at Yonsei University. Results showed no statistical 
differences in the amounts of urine I/Cr or urine creatinine 
in each group between the 2-week and 4-week restricted 
diet groups, and no differences between the RID and LID 
groups. Moreover, as for the amounts of radioiodine con-
sumption for a 4-week restricted diet, the two groups did not 
show a difference. Therefore, with systematic education for 
the patients, RID for 2 weeks can be considered for radioio-
dine ablation therapy after a total thyroidectomy. Moreover, 
it is expected that this may improve patient quality of life. In 
this study, the consumption amount was measured only for a 
4-week restricted diet. Rather than conducting research with 
different patients and dividing them into 2-week and 4-week 
restricted diet groups, we thought it to be more accurate to 
work with the same patients. Moreover, if they were to be 
included in the range of optimal figures for treatment with 
little difference in urine I/Cr, we considered that the gap in 
the amount of radioiodine consumption would not be signif-
icant. Although patients with progressive or relapsing thy-
roid carcinoma were excluded, we hope that the RID can be 
expanded by analyzing the prognosis related to a restricted 
diet through monitoring of research subjects in the future.
In this study, the amounts of urine iodine and urine creati-
nine were compared and analyzed by setting 2-week and 
4-week diet durations for the LID and RID group, and there 
were no differences between the durations; a comparison 
between the two diets also showed no differences. The two 
diets did not show any difference in the amounts of radioio-
dine consumption for a 4-week restricted diet. Therefore, 
when developing an adaptability plan for patients using the 
LID for radioiodine ablation therapy, it is reasonable to con-
sider a 2-week RID after ensuring strict education for the 
patients, in order to improve their quality of life.
Furthermore, if patients do not receive proper diet educa-
tion, they may proceed with ambiguous iodine restriction 
between the RID and LID. For the application of the RID in 
a clinical setting, the importance of thorough patient educa-
tion cannot be overemphasized.
This is a preliminary study showing that 4-week LID and 
RID are unnecessary. Although we did not apply objective 
method to analyzing the quality of life, it is quite possible 
that it made patient’s quality of life worse.
In extension of this preliminary results, we are in a pro-
volume of residual thyroid tissues can be slightly different 
because the operation methods can vary according to the 
institution in the case of cooperative research at multiple in-
stitutions. This can cause statistical bias. We conducted our 
research with patients undergoing surgeries with the same 
operation methods at a single institution, which should min-
imize statistical prejudice. To compare the amount of urine 
I/Cr, the amounts at the 2nd and 4th weeks were compared 
for each group. In the LID group, the average amount of 
urine I/Cr for the 2nd and 4th weeks were 28.6 ug/gCr 
(3.7‒107) and 35.0 ug/gCr (3.5‒185.9), respectively, show-
ing a rather lower I/Cr average amount for a 2-week re-
stricted diet, but with no statistical meaning. The amount of 
urine I/Cr was >100 ug/gCr in one case of the 2-week re-
stricted diet and in two cases of the 4-week restricted diet. 
This might have occurred because the average amount of 
urine creatinine was 110 mg/dL (11.7‒452.7) for the 2- 
week restricted diet, which is higher than the figure of 94.3 
mg/dL (19.7‒419.5) for the 4-week restricted diet. Howev-
er, it should be considered that compliance for some of the 
patients decreased as the duration of the diet was extended. 
In the RID group, the average amounts of urine I/Cr mea-
sured at the 2nd and the 4th week were 35.8 ug/gCr (3.7‒ 
142.3) and 35.0 ug/gCr (1.9‒152.6), showing a slightly low-
er amount for the 4-week restricted diet, but this had no 
statistical importance. This arose because the average 
amount of urine creatinine for the 2-week diet was 103.1 
mg/dL (11.1‒378.7), which was less than that of the 4-week 
diet, at 112.9 mg/dL (11.6‒452.7). The amount of urine I/Cr 
was >100 ug/gCr for four cases in the 2-week restricted diet 
group and two casesin the 4-week restricted diet group. The 
LID figure for amount of urine I/Cr was less in the 2-week 
restricted diet than the RID, whereas in the 4-week diet, the 
two groups showed same amount. However, both figures 
were included in the range of <50 ug/gCr, which is the re-
quired amount for radioiodine ablation therapy. I-131 whole 
body scan was performed once at 2 days after I-131 admin-
istration, and thyroid uptake was performed at 2 hours and 
24 hours after I-131 administration, with both showing no 
Table 6. Comparison of Radioiodine Consumption between 
the LID and RID Groups
Radioiodine  
uptake
Diet
p value
LID RID
After 2 hrs (%)* 1.95 (0.67) 1.83 (0.83) 0.811
After 24 hrs (%)* 2.78 (2.62) 2.69 (4.05) 0.721
LID, low iodine diet; RID, restricted iodine diet.
*Mean standard deviation.
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